Upregulation of SEPT7 Gene Inhibits Invasion of Human Glioma Cells

REFERENCES

• Stupp, R.; Mason, W.P.; van Den Bent, M.J.; Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352(10), 987–996.
   PubMed Web of Science ®Google Scholar
• Hartwell, L.H. Genetic control of the cell division cycle in yeast IV genes controlling bud emergence and cytokinesis. Exp Cell Res 1971, 69(2), 265–276.
   PubMed Web of Science ®Google Scholar
• Sirajuddin, M.; Farkasovsky, M.; Hauer, F.; Structural insight into filament formation by mammalian septins. Nature 2007, 449(7160), 311–315.
   PubMed Web of Science ®Google Scholar
• Low, C.; Macara, I.G. Structural analysis of Septin 2,6 and 7 complexes. J Biol Chem 281(2006), 30697–30706.
   PubMed Web of Science ®Google Scholar
• Kremer, B.E.; Haystead, T.; Macara, I.G. Mammalian septins regulate microtubule stability through interaction with the microtubule-binding protein MAP4. Mol Biol Cell 2005, 16, 4648–4659.
   Web of Science ®Google Scholar
• Nagata, K.; Asano, T.; Nozawa, Y.; Inagaki, M. Biochemical and cell biological analyses of a mammalian septin complex SEPT7/9b/11. J Biol Chem 2004, 279, 55895–55904.
   PubMed Web of Science ®Google Scholar
• Xie, Y.; Vessey, J.P.; Konecna, A.; The GTP-binding protein septin 7 is critical for dendrite branching and dendritic-spine morphology. Curr Biol 2007, 10, 1746–1751.
   Google Scholar
• Hall, P.A.; Russell, S.E. The pathobiology of the septin gene family. J Pathol 2004, 204, 489–505.
   PubMed Web of Science ®Google Scholar
• Xie, Y.; Vessey, J.P.; Konecna, A.; The GTP-binding protein Septin 7 is critical for dendrite branching and dendritic-spine morphology. Curr Biol 2007, 17, 1746–1751.
   PubMed Web of Science ®Google Scholar
• Zhu, M.; Wang, F.; Yan, F.; Septin 7 interacts with centromere-associated protein E and is required for its kinetochore localization. J Biol Chem 2008, 283, 18916–18925.
   PubMed Web of Science ®Google Scholar
• Kremer, B.E.; Adang, L.A.; Macara, I.G. Septins regulate actin organization and cell-cycle arrest through nuclear accumulation of NCK mediated by SOCS7. Cell 2007, 130, 837–850.
   Google Scholar
• Hall, P.A.; Russell, S.E. The pathobiology of the septin gene family. J Pathol 2004, 204, 489–505.
   PubMed Web of Science ®Google Scholar
• Megonigal, M.D.; Rappaport, E.F.; Jones, D.H.; t(11;22)(q23;q11.2) in acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes. Proc Natl Acad Sci USA 1998, 95, 6413–6418.
   PubMed Web of Science ®Google Scholar
• Ono, R.; Taki, T.; Taketani, T.; SEPTIN6, a human homologue to mouse Septin6, is fused to MLL in infant acute myeloid leukemia with complex chromosomal abnormalities involving 11q23 and Xq24. Cancer Res 2002, 62, 333–337.
   PubMed Web of Science ®Google Scholar
• Osaka, M.; Rowley, J.D.; Zeleznik-Le, N.J. MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25). Proc Natl Acad Sci USA 1999, 96, 6428–6433.
   PubMed Web of Science ®Google Scholar
• Kojima, K.; Sakai, I.; Hasegawa, A.; FLJ10849, a septin family gene, fuses MLL in a novel leukemia cell line CNLBC1 derived from chronic neutrophilic leukemia in transformation with t(4;11)(q21;q23). Leukemia 2004, 18, 998–1005.
   PubMed Web of Science ®Google Scholar
• Kalikin, L.M.; Sims, H.L.; Petty, E.M. Genomic and expression analyses of alternatively spliced transcripts of the MLL septin-like fusion gene (MSF) that map to a 17q25 region of loss in breast and ovarian tumors. Genomics 2000, 63, 165–172.
   PubMed Web of Science ®Google Scholar
• Montagna, C.; Lyu, M.S.; Hunter, K.; The septin 9 (MSF) gene is amplified and over expressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res 2003, 63, 2179–2187.
   PubMed Web of Science ®Google Scholar
• Burrows, J.F.; Chanduloy, S.; McIlhatton, M.A.; Altered expression of the septin gene, SEPT9, in ovarian neoplasia. J Pathol 2003, 201, 581–588.
   PubMed Web of Science ®Google Scholar
• Sakai, K.; Kurimoto, M.; Tsugu, A.; Expression of Nedd5, a mammalian septin, in human brain tumors. J Neurooncol 2002, 57, 169–177.
   PubMed Web of Science ®Google Scholar
• Kim, D.S.; Hubbard, S.L.; Peraud, A.; Analysis of mammalian septin expression in human malignant brain tumours. Neoplasia 2004, 6, 168–178.
   PubMed Web of Science ®Google Scholar
• Scott, M.; Hyland, P.; McGregor, G.; Multimodality expression profiling shows SEPT9 to be over-expressed in a wide range of human tumours. Oncogene 2005, 24, 4688–4700.
   PubMed Web of Science ®Google Scholar
• Kinoshita, A.; Kinoshita, M.; Akiyama, H.; Identification of septins in neurofibrillary tangles in Alzheimer's disease. Am J Pathol 1998, 153, 1551–1560.
   PubMed Web of Science ®Google Scholar
• Cheon, M.S.; Fountoulakis, M.; Dierssen, M.; Ferreres, J.C.; Lubec, G. Expression profiles of proteins in fetal brain with Down syndrome. J Neural Transm Suppl 2001, 61, 311–319.
   PubMedGoogle Scholar
• Engidawork, E.; Gulesserian, T.; Fountoulakis, M.; Lubec, G. Aberrant protein expression in cerebral cortex of fetus with Down syndrome. Neuroscience 2003, 122, 145–154.
   PubMed Web of Science ®Google Scholar
• Ihara, M.; Tomimoto, H.; Kitayama, H.; Association of the cytoskeletal GTP-binding protein Sept4/H5 with cytoplasmic inclusions found in Parkinson's disease and other synucleinopathies.J Biol Chem 2003, 278, 24095–24102.
   PubMed Web of Science ®Google Scholar
• Huang, H.; Colella, S.; Kurrer, M.; Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays. Cancer Res 2000, 60, 6868–6874.
   PubMed Web of Science ®Google Scholar
• Nagata, T.; Takahashi, Y.; Asai, S.; The high level of SEPT7/hCDC10 gene expression in neuroblastoma may be associated with favorable characteristics of the tumor. J Surg Res 2000, 92, 267–275.
   PubMed Web of Science ®Google Scholar
• Hall, P.A.; Jung, K.; Hillan, K.J.; Russell, S.E. Expression profiling the human septin gene family. J Pathol 2005, 206,269–278.
   PubMedGoogle Scholar
• Jiang, R.C.; Pu, P.Y.; shen, C.H.; Preliminary study on cancer-related gene expression profiles in 63 cases of gliomas by cDNA array. Chin J Neurosurg 2004, 1, 21–24.
   Google Scholar
• Jia, Z.F.; Pu, P.Y.; Kang, C.S.; Study on the expression of SEPT7/hCDC10 in astrocytic gliomas. Chin J Neurosurg 2006, 22, 636–639.
   Google Scholar
• Jia, Z.F.; Pu, P.Y.; Kang, C.S.; Influence of SEPT7 on biological characters of glioma cell line TJ905. Zhonghua Wai Ke Za Zhi 2007, 45, 1420–1423.
   PubMedGoogle Scholar
• Wang, S.L.; Li, F.; Pu, P.Y.; The establishment and characteristics of human glioblastoma cell lines TJ899 and TJ905. J Tianjin Med 1996, 12, 416–418.
   Google Scholar
• Mohan, P.M.; Chintala, S.K.; Mohanam, S.; Adenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growth. Cancer Res 1999, 59, 3369–3373.
   PubMed Web of Science ®Google Scholar
• Jia, Z.F.; Pu, P.Y.; Kang, C.S.; Effect of SEPT7 on the malignant phenotype of transplanted glioma in nude mice. Chin J Oncol 2008, 30, 3–7.
   Google Scholar
• Liotta, L.A. Tumor invasion and metastasis role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res 1986, 46, 1–7.
   PubMed Web of Science ®Google Scholar
• Bello, L.; Francolini, M.; Marthyn, P.; Alpha(v) beta 3 and alpha(v) beta 5 integrin expression in glioma periphery. Neurosurgery 2001, 49, 380–389.
   PubMed Web of Science ®Google Scholar
• Bello, L.; Lucini, V.; Giussani, C.; IS20I, a specific alphavbeta3 integrin inhibitor, reduces glioma growth in vivo. Neurosurgery 2003, 52, 177–185.
   PubMed Web of Science ®Google Scholar
• Guo, P.; Imanishi, Y.; Cackowski, F.C.; Upregulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma. Am J Pathol 2005, 166,877–890.
   PubMed Web of Science ®Google Scholar
• Nakado, M.; Kita, D.; Futamik, K.; Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinase 2 in invasion and dissemination of human malignant glioma.J Neurosurg 2001, 94, 464–473.
   PubMed Web of Science ®Google Scholar
• Lakka, S.S.; Rajan, M.; Gondi, C.; Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene 2002, 21, 8011–8819.
   PubMed Web of Science ®Google Scholar
• Nuttall, R.K.; Pennington, C.J.; Taplin, J.; Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells. Mol Cancer Res 2003, 1, 333–345.
   PubMed Web of Science ®Google Scholar
• Gomez, D.E.; Alonso, D.F.; Yoshiji, H.; Thorgeirsson, U.P. Tissue inhibitors of metalloproteinases: structure, regulation, and biological functions. Eur J Cell Biol 1997, 74, 111–122.
   PubMed Web of Science ®Google Scholar
• Yin, Z.Q., Hou, R.G.; Wang, T.; The expression and significance of MMP-2 and TIMP-2 in gliomas. Chin J Neuromed 2005, 4, 1097–1100.
   Google Scholar
• Lampert, K.; Machein, M.R.; Conca, W.; Expression of matrix metalloproteinases and the tissue inhibitors in human brain tumors. Am J Pathol 1998, 153, 429–437.
   PubMed Web of Science ®Google Scholar
• Nakano, A.; Tani, E.; Yamamoto, Y.; Increased expression of gelatinases A and B, matrilysin and TIMP1 genes in human malignant gliomas. Nippon Rinsho 1995, 53, 1816–1821.
   PubMedGoogle Scholar
• Gerharz, C., Mou, R.; Meister, P.; Cytoskeletal heterogeneity of an epithelioid sarcoma with expression of vimentin, cytokeratin, and neurofilaments. Am J Surg Pathol 1990, 14, 274–282.
   PubMed Web of Science ®Google Scholar
• Sabine, H.; Patricia, C.; Laila, S.; IL-2-dependent expression of genes involved in cytoskeleton organization, oncogene regulation, and transcriptional control. J Immunol 1999, 162, 3280–3288.
   PubMed Web of Science ®Google Scholar